Home › Breast Cancer › North Carolina › Asheville
Breast Cancer clinical trials in Asheville, NC
3 studies for Breast Cancer are looking for participants at sites in and around Asheville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- AdventHealth Infusion Center Asheville, Asheville
- AdventHealth Infusion Center Weaverville, Weaverville · 7 mi away
- AdventHealth Hendersonville, Hendersonville · 20 mi away
- and 1 more
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- Messino Cancer Centers, Asheville
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Mission Hospital, Asheville
- Hope Women's Cancer Centers-Asheville, Asheville
- Margaret R Pardee Memorial Hospital, Hendersonville · 20 mi away
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Asheville
- Heart Failure7 studies
- Non-Small Cell Lung Cancer5 studies
- Acute Lymphoblastic Leukemia4 studies
- Acute Myeloid Leukemia4 studies
- Chronic Lymphocytic Leukemia4 studies
- Burkitt Lymphoma4 studies
- Cardiovascular Disease4 studies
- Lung Cancer4 studies
- Acute Biphenotypic Leukemia3 studies
- Melanoma3 studies
- Graves Disease3 studies
- Hyperthyroidism3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.